What is the Carboplatin Dose Calculator?
This tool calculates the total dose of carboplatin, a platinum-based chemotherapy agent, using the Calvert formula. Unlike many cytotoxic drugs that are dosed by body surface area, carboplatin is dosed to achieve a target area under the concentration–time curve (AUC), because its clearance correlates closely with renal function. This calculator is intended as an educational and clinical aid; all doses must be verified by a qualified oncology pharmacist or physician before administration.
How to use it
Enter the target AUC (commonly 4–6 mg/mL·min depending on the regimen and whether carboplatin is given as a single agent or in combination) and the patient's GFR (glomerular filtration rate, in mL/min, often estimated by the Cockcroft–Gault equation). The calculator multiplies and adds to return the total dose in milligrams.
The formula explained
The Calvert formula is: $$\text{Dose (mg)} = \text{AUC} \times \left( \text{GFR} + 25 \right)$$. The constant 25 represents the non-renal clearance of carboplatin. GFR is expressed in mL/min and AUC in mg/mL·min, so the product yields milligrams. Many institutions cap the GFR used in the formula (e.g. at 125 mL/min) to avoid overdosing patients with overestimated renal function.
With the cap applied, the Calvert formula is: $$\text{Dose (mg)} = \text{Target AUC} \times \left( \min(\text{GFR}, 125) + 25 \right)$$. When the entered GFR is above 125 mL/min, NCI CTEP guidance (2010) caps the GFR used in the Calvert formula at 125 mL/min, so the dose cannot exceed Target AUC × 150 mg.
Worked example
For a patient with a target AUC of 5 and a GFR of 80 mL/min: $$\text{Dose} = 5 \times (80 + 25) = 5 \times 105 = 525 \text{ mg}$$
Typical Target AUC Values by Regimen
The target AUC (area under the concentration–time curve, in mg/mL·min) is chosen by the treatment protocol, not by the calculator. The ranges below are commonly published values, shown for orientation only.
| Setting | Commonly published target AUC | Notes |
|---|---|---|
| Single agent, previously treated patients | 4–6 | Lower values are often used when marrow reserve is limited. |
| Single agent, previously untreated patients | 6–8 (some older protocols) | Higher targets appear mainly in older protocols and are less common in current practice. |
| Combination regimens | 4–6 | Often lower than single-agent targets because of overlapping toxicity. |
| Combination with paclitaxel | 5–6 | A frequently cited range for carboplatin plus paclitaxel. |
Important: target AUC values depend on the protocol, the tumor type, the patient's prior therapy and the patient's condition. Always confirm the AUC against the local protocol or the prescribing clinician's orders.
Dose Comparison Across GFR and AUC Scenarios
Each value is calculated as \(\text{Dose (mg)} = \text{AUC} \times (\text{GFR} + 25)\), with GFR in mL/min.
| Target AUC | GFR 30 | GFR 60 | GFR 90 | GFR 125 (cap) |
|---|---|---|---|---|
| AUC 4 | 4 × 55 = 220 mg | 4 × 85 = 340 mg | 4 × 115 = 460 mg | 4 × 150 = 600 mg |
| AUC 5 | 5 × 55 = 275 mg | 5 × 85 = 425 mg | 5 × 115 = 575 mg | 5 × 150 = 750 mg |
| AUC 6 | 6 × 55 = 330 mg | 6 × 85 = 510 mg | 6 × 115 = 690 mg | 6 × 150 = 900 mg |
Maximum doses when GFR is capped at 125 mL/min: AUC 4 = 600 mg, AUC 5 = 750 mg, AUC 6 = 900 mg.
Worked example: for AUC 5 and GFR 60 mL/min, \(5 \times (60 + 25) = 5 \times 85 = 425\) mg.
Interpreting the Calculated Dose
- Total dose, not per m². The result is the total carboplatin dose in mg for one administration. It is not scaled to body surface area.
- Linear relationship. Dose rises in direct proportion to the target AUC. It also rises linearly with GFR, with a fixed offset of 25 in the formula. For example, raising the AUC from 5 to 6 at the same GFR increases the dose by 20%.
- The GFR estimate matters. The result is only as reliable as the GFR input. GFR may be measured directly or estimated, for example with the Cockcroft–Gault equation. Creatinine assays standardized to IDMS (isotope dilution mass spectrometry) can give lower values than older assays, which can lead to overestimated GFR and higher doses unless the estimate is handled according to institutional policy. Institutions differ in how they handle low creatinine values and in the weight used for the estimate.
- GFR cap of 125 mL/min. The FDA has recommended capping the estimated GFR at 125 mL/min to avoid overdosing. This gives a maximum dose of \(\text{AUC} \times 150\) mg: 600 mg for AUC 4, 750 mg for AUC 5 and 900 mg for AUC 6. This calculator applies the cap automatically: a GFR above 125 mL/min is used as 125 and a warning is shown.
This tool is for education only. It is general information, not professional advice. Carboplatin doses must always be calculated, checked and approved by qualified clinicians using the current protocol and the patient's own data.
FAQ
What AUC should I use? Typical values are AUC 5–6 for single-agent therapy and AUC 4–5 in combination regimens; follow your local protocol.
Should I cap the GFR? Many guidelines recommend capping calculated GFR at 125 mL/min to prevent overdosing. This calculator applies the 125 mL/min cap automatically and shows a warning when it does.
Is this a substitute for clinical judgement? No. Always confirm the dose against patient-specific factors and institutional policy.